Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 5 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a Pancreatic Cancer Xenograft Model.
Int J Mol Sci. 2023 Feb 2;24(3):2838. doi: 10.3390/ijms24032838.
Int J Mol Sci. 2023.
PMID: 36769161
Free PMC article.
Experimental Therapy of HER2-Expressing Xenografts Using the Second-Generation HER2-Targeting Affibody Molecule 188Re-ZHER2:41071.
Liu Y, Vorobyeva A, Orlova A, Konijnenberg MW, Xu T, Bragina O, Loftenius A, Rosander E, Frejd FY, Tolmachev V.
Liu Y, et al.
Pharmaceutics. 2022 May 20;14(5):1092. doi: 10.3390/pharmaceutics14051092.
Pharmaceutics. 2022.
PMID: 35631678
Free PMC article.
Item in Clipboard
Direct In Vivo Comparison of 99mTc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy.
Tolmachev V, Bodenko V, Oroujeni M, Deyev S, Konovalova E, Schulga A, Lindbo S, Hober S, Bragina O, Orlova A, Vorobyeva A.
Tolmachev V, et al.
Int J Mol Sci. 2022 Dec 2;23(23):15181. doi: 10.3390/ijms232315181.
Int J Mol Sci. 2022.
PMID: 36499504
Free PMC article.
Item in Clipboard
Preclinical Evaluation of a New Format of 68Ga- and 111In-Labeled Affibody Molecule ZIGF-1R:4551 for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT.
Liu Y, Yu S, Xu T, Bodenko V, Orlova A, Oroujeni M, Rinne SS, Tolmachev V, Vorobyeva A, Gräslund T.
Liu Y, et al.
Pharmaceutics. 2022 Jul 15;14(7):1475. doi: 10.3390/pharmaceutics14071475.
Pharmaceutics. 2022.
PMID: 35890370
Free PMC article.
Item in Clipboard
Biologic Evaluation of a Heterodimeric HER2-Albumin Targeted Affibody Molecule Produced by Chemo-Enzymatic Peptide Synthesis.
Liu Y, Güler R, Liao Y, Vorobyeva A, Widmark O, Meuleman TJ, Koijen A, van den Bos LJ, Naasz R, Bodenko V, Orlova A, Ekblad C, Tolmachev V, Frejd FY.
Liu Y, et al.
Pharmaceutics. 2022 Nov 19;14(11):2519. doi: 10.3390/pharmaceutics14112519.
Pharmaceutics. 2022.
PMID: 36432709
Free PMC article.
Item in Clipboard
Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity Protein.
Garousi J, Ding H, von Witting E, Xu T, Vorobyeva A, Oroujeni M, Orlova A, Hober S, Gräslund T, Tolmachev V.
Garousi J, et al.
Pharmaceutics. 2021 Nov 3;13(11):1847. doi: 10.3390/pharmaceutics13111847.
Pharmaceutics. 2021.
PMID: 34834262
Free PMC article.
Item in Clipboard
Comparative Preclinical Evaluation of Peptide-Based Chelators for the Labeling of DARPin G3 with 99mTc for Radionuclide Imaging of HER2 Expression in Cancer.
Larkina M, Plotnikov E, Bezverkhniaia E, Shabanova Y, Tretyakova M, Yuldasheva F, Zelchan R, Schulga A, Konovalova E, Vorobyeva A, Garousi J, Gräslund T, Belousov M, Tolmachev V, Deyev S.
Larkina M, et al.
Int J Mol Sci. 2022 Nov 3;23(21):13443. doi: 10.3390/ijms232113443.
Int J Mol Sci. 2022.
PMID: 36362226
Free PMC article.
Item in Clipboard
Cite
Cite